Schizophrenia and Schizoaffective Disorders (Pediatric) Clinical Trials

A listing of Schizophrenia and Schizoaffective Disorders (Pediatric) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 4 clinical trials
A Study to Assess the Treatment of Schizophrenia With Paliperidone Palmitate in Rwandan Healthcare Settings

The purpose of this study is to assess the effect of treatment with long-acting injectable (LAI) paliperidone (paliperidone palmitate 1-month [PP1M] and 3-month [PP3M] formulations) in terms of clinical outcomes in participants with schizophrenia in Rwandan real-world healthcare settings.

oral risperidone
  • 01 Aug, 2021
  • 3 locations
Lumateperone for the Prevention of Relapse in Patients With Schizophrenia

This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, fixed-dose study in adult patients with a primary diagnosis of schizophrenia according to criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, (DSM-5).

psychotic episode
structured clinical interview
  • 25 Jul, 2021
  • 19 locations
Neural Correlates of Social Touch and Interoceptive Perception as Potential Biomarker for Impaired Social Functioning

Recent studies have shown that certain biomarkers of schizophrenia could help to better assess the individual course of the disease and thus, contribute to more personalized treatment options. The aim of the SPIRIT study is to identify potential biomarkers for the prediction of disease-associated outcomes by investigating the neurobiological mechanisms …

  • 27 Jul, 2021
  • 1 location
Aging and Disease Course: Contributions to Lifespan Neurobiology of Schizophrenia

The 2020 NIMH Strategic Plan for Research calls for investigations targeting neurobiology of mental illness across the lifespan. Growing evidence suggests that lifespan neurobiology of schizophrenia (SZ) incorporates two distinct dimensions: aging and disease course. However, their clinical correlates, associated biomarker trajectories, and implications for treatment are unknown. This study …

schizoaffective disorder
  • 22 Jul, 2021
  • 1 location